<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Peripheral leucocytes from nasopharyngeal <z:mp ids='MP_0002038'>carcinoma</z:mp> (NPC) patients and control subjects, which included healthy subjects and patients with other <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e>, have been tested against <z:chebi fb="48" ids="51403,53543">PPD</z:chebi> and a panel of extracts from Raji cells and pooled NPC biopsies, using the blast transformation and the macrophage migration inhibition assays </plain></SENT>
<SENT sid="1" pm="."><plain>The results of both assays indicated that the in vitro cell-mediated immune (CMI) responses to the Raji-cell extracts and NPC-biopsy extracts were associated with NPC </plain></SENT>
<SENT sid="2" pm="."><plain>However, the peripheral leucocytes from NPC patients and control subjects responded similarly to <z:chebi fb="48" ids="51403,53543">PPD</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>These results are in general accord with the skin tests reported by Levine et al </plain></SENT>
<SENT sid="4" pm="."><plain>(1976) and Ho, Ng and Kwan (1977b) </plain></SENT>
<SENT sid="5" pm="."><plain>The antigenic specificity of the NPC-associated CMI responses remains, however, to be resolved, as the extracts used in these or in the in vivo CMI studies were <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> mixtures </plain></SENT>
</text></document>